Application of Metabonomics in Substance Abuse Toxicology Research

doi:10.12116/j.issn.1004-5619.2019.391203

Abstract

Abstract:

Abstrct: Metabonomics is a relative discipline that develops after genomics and proteomics, and it is an important component of systems biology. It uses high-throughput and high-sensitivity instruments to perform qualitative and quantitative analysis of all metabolic components in specific biological samples under limited conditions and combines with multivariate statistics to analyze and process the data to obtain information about physiological, pathological or toxicological changes in organisms. In recent years, because of the complicated mechanism of substance abuse and the continuous emergence of new psychoactive substances, metabonomics is increasingly used in substance abuse research. Therefore, this article reviews the application of metabonomics of substance abuse in the toxic mechanism, the mechanism of addiction and the discovery of biomarkers.

Key words: forensic toxicology, metabonomics, substance abuse, biomarkers, toxic mechanisms, review

CLC Number:

DF795.1

Xiu-ying YAN, Ping XIANG, Zhi-guo YU, Hui YAN. Application of Metabonomics in Substance Abuse Toxicology Research[J]. Journal of Forensic Medicine, 2022, 38(3): 400-407.

References 62

1	沈敏，向平. 滥用物质分析与应用[M].北京：科学出版社，2016.
	SHEN M， XIANG P. Analysis and application of substance abuse[M]. Beijing： Science Press，2016.
2	徐多麒，王继芬，孟品佳. 新精神活性物质的特点及危害[C]//第五届全国“公共安全领域中的化学问题”暨第三届危险物质与安全应急技术研讨会.银川，2015.
	XU D Q， WANG J F， MENG P J. Characteristics and harm of new psychoactive substances[C]//The fifth national “chemical problems in the field of public safety” and the third symposium on hazardous substances and safety emergency technology. Yinchuan，2015.
3	DREXLER D M， REILY M D， SHIPKOVA P A. Advances in mass spectrometry applied to pharmaceutical metabolomics[J]. Anal Bioanal Chem，2011，399（8）：2645-2653. doi：10.1007/s00216-010-4370-8 .
4	KUMAR B S， LEE Y J， YI H J， et al. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach[J]. Anal Chimica Acta，2010，661（1）：47-59. doi：10.1016/j.aca.2009.11.063 .
5	SUGIMOTO M， WONG D T， HIRAYAMA A， et al. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral， breast and pancreatic cancer-specific profiles[J]. Metabolomics，2010，6（1）：78-95. doi：10.1007/s11306-009-0178-y .
6	SHIMA N， MIYAWAKI I， BANDO K， et al. Influences of methamphetamine-induced acute intoxication on urinary and plasma metabolic profiles in the rat[J]. Toxicology，2011，287（1/2/3）：29-37. doi：10.1016/j.tox.2011.05.012 .
7	ZHENG T， LIU L， SHI J， et al. The metabolic impact of methamphetamine on the systemic metabolism of rats and potential markers of methamphetamine abuse[J]. Mol Biosyst，2014，10（7）：1968-1977. doi：10.1039/c4mb00158c .
8	KADDURAH-DAOUK R， KRISTAL B S， WEIN-SHILBOUM R M. Metabolomics： A global biochemical approach to drug response and disease[J]. Annu Rev Pharmacol Toxicol，2008，48：653-683. doi：10.1146/annurev.pharmtox.48.113006.094715 .
9	UDDIN R K， SINGH S M. Metabolomics in Drug Response and Addiction[M]//JOHNSON B. Addiction medicine. New York： Sringer，2011：237-253. doi：10.1007/978-1-4419-0338-9_12 .
10	VOLKOW N D， KOOB G， BALER R. Biomarkers in substance use disorders[J]. ACS Chem Neurosci，2015，6（4）：522-525. doi：10.1021/acschemneuro.5b00067 .
11	BLANCHOT J， RODIER M， LE BOUTEILLER A. Effect of El Niño Southern Oscillation events on the distribution and abundance of phytoplankton in the Western Pacific Tropical Ocean along 165°E[J]. J Plankton Res，1992，14（1）：137-156. doi：10.1093/plankt/14.1.137 .
12	NESTLER E J. Is there a common molecular pathway for addiction? [J]. Nat Neurosci，2005，8（11）：1445-1449. doi：10.1038/nn1578 .
13	OLDENDORF W H， HYMAN S， BRAUN L， et al. Blood-brain barrier： Penetration of morphine， codeine， heroin， and methadone after carotid injection[J]. Science，1972，178（4064）：984-986. doi：10.1126/science.178.4064.984 .
14	LI R S， TAKEDA T， OHSHIMA T， et al. Metabolomic profiling of brain tissues of mice chronically exposed to heroin[J]. Drug Metab Pharmacokinet，2017，32（1）：108-111. doi：10.1016/j.dmpk.2016.10.410 .
15	LI L， LI J Y， CAO H J， et al. Determination of metabolic phenotype and potential biomarkers in the liver of heroin addicted mice with hepatotoxicity[J]. Life Sci，2021，287：120103. doi：10.1016/j.lfs.2021. 120103 .
16	LI Y Y， GHANBARI R， PATHMASIRI W， et al. Untargeted metabolomics： Biochemical perturbations in golestan cohort study opium users inform intervention strategies[J]. Front Nutr，2020，7：584-585. doi：10.3389/fnut.2020.584585 .
17	JIANG S K， LIU G J， YUAN H Y， et al. Changes on proteomic and metabolomic profile in serum of mice induced by chronic exposure to tramadol[J]. Sci Rep，2021，11：1454. doi：10.1038/s41598-021-81109-7 .
18	XIA W， LIU G J， SHAO Z Y， et al. Toxicology of tramadol following chronic exposure based on metabolomics of the cerebrum in mice[J]. Sci Rep，2020，10：11130. doi：10.1038/s41598-020-67974-8 .
19	FLECKENSTEIN A E， METZGER R R， GIBB J W， et al. A rapid and reversible change in dopamine transporters induced by methamphetamine[J]. Eur J Pharmacol，1997，323（2/3）： R9-R10. doi：10.1016/S0014-2999（97）00148-9 .
20	PIFL C， DROBNY H， REITHER H， et al. Mechanism of the dopamine-releasing actions of ampheta-mine and cocaine： Plasmalemmal dopamine transporter versus vesicular monoamine transporter[J]. Mol Pharmacol，1995，47（2）：368-373.
21	COSTA T B B C， LACERDA A L T， MAS C D， et al. Insights into the effects of crack abuse on the human metabolome using a NMR approach[J]. J Proteome Res，2019，18（1）：341-348. doi：10.1021/acs.jproteome.8b00646 .
22	雷啟芬，朱丹. 代谢组学在药物滥用毒理学中的应用[J].航天医学与医学工程，2017，30（3）：230-234. doi：10.16289/j.cnki.1002-0837.2017.03.014 .
	LEI Q F， ZHU D. Application of metabolomics on toxicology of drugs abuse[J]. Hangtian Yixue Yu Yixue Gongcheng，2017，30（3）：230-234.
23	SÁNCHEZ-LÓPEZ E， MARCOS A， AMBROSIO E， et al. Investigation on the combined effect of cocaine and ethanol administration through a liquid chromatography-mass spectrometry metabolomics approach[J]. J Pharm Biomed Anal，2017，140：313-321. doi：10.1016/j.jpba.2017.03.061 .
24	DARKE S， DARKE S， KAYE S， et al. Major physical and psychological harms of methamphetamine use[J]. Drug Alcohol Rev，2008，27（3）：253-262. doi：10.1080/09595230801923702 .
25	HOMER B D， SOLOMON T M， MOELLER R W， et al. Methamphetamine abuse and impairment of social functioning： A review of the underlying neurophysiological causes and behavioral implications[J]. Psychol Bull，2008，134（2）：301-310. doi：10.1037/0033-2909.134.2.301 .
26	MCCLAY J L， ADKINS D E， VUNCK S A， et al. Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure[J]. Metabolomics，2013，9（2）：392-402. doi：10.1007/s11306-012-0456-y .
27	ARAÚJO A M， BASTOS M L， FERNANDES E， et al. GC-MS metabolomics reveals disturbed metabolic pathways in primary mouse hepatocytes exposed to subtoxic levels of 3，4-methylenedioxymethamphetamine （MDMA）[J]. Arch Toxicol，2018，92（11）：3307-3323. doi：10.1007/s00204-018-2314-9 .
28	BOXLER M I， STREUN G L， LIECHTI M E， et al. Human metabolome changes after a single dose of 3，4-methylenedioxymethamphetamine （MDMA） with special focus on steroid metabolism and inflammation processes[J]. J Proteome Res，2018，17（8）：2900-2907. doi：10.1021/acs.jproteome.8b00438 .
29	NIELSEN K L， TELVING R， ANDREASEN M F， et al. A metabolomics study of retrospective forensic data from whole blood samples of humans exposed to 3，4-methylenedioxymethamphetamine： A new approach for identifying drug metabolites and changes in metabolism related to drug consumption[J]. J Proteome Res，2016，15（2）：619-627. doi：10.1021/acs.jproteome.5b01023 .
30	CHEN F， YE Y， DAI X H， et al. Metabolic effects of repeated ketamine administration in the rat brain[J]. Biochem Biophys Res Commun，2020，522（3）：592-598. doi：10.1016/j.bbrc.2019.11.140 .
31	WEN C， ZHANG M， ZHANG Y， et al. Brain metabolomics in rats after administration of ketamine[J]. Biomed Chromatogr，2016，30（1）：81-84. doi：10.1002/bmc.3518 .
32	WU Z G， CHEN F， WU H， et al. Urinary metabonomics of rats with ketamine-induced cystitis using GC-MS spectroscopy[J]. Int J Clin Exp Pathol，2018，11（2）：558-567.
33	ZHANG M L， WEN C C， ZHANG Y， et al. Serum metabolomics in rats models of ketamine abuse by gas chromatography-mass spectrometry[J]. J Chromatogr B，2015，1006：99-103. doi：10.1016/j.jchromb.2015.10.037 .
34	HAN X， SHAO W， LIU Z， et al. iTRAQ-based quantitative analysis of hippocampal postsynaptic density-associated proteins in a rat chronic mild stress model of depression[J]. Neuroscience，2015，298：220-292. doi：10.1016/j.neuroscience.2015.04.006 .
35	KITAMURA Y， DOI M， KUWATSUKA K， et al. Chronic treatment with imipramine and lithium increases cell proliferation in the hippocampus in adrenocorticotropic hormone-treated rats[J]. Biol Pharm Bull，2011，34（1）：77-81. doi：10.1248/bpb.34.77 .
36	LIAN B， XIA J， YANG X， et al. Mechanisms of ketamine on mice hippocampi shown by gas chromatography-mass spectrometry-based metabolomic analysis[J]. Neuroreport，2018，29（9）：704-711. doi：10.1097/wnr.0000000000001020 .
37	WECKMANN K， LABERMAIER C， ASARA J M， et al. Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates[J]. Transl Psychiatry，2014，4（11）： e481. doi：10.1038/tp.2014.119 .
38	DHUMMAKUPT E S， RIZZO G M， FEASEL M， et al. Proteomic and metabolomic profiling identify plasma biomarkers for exposure to ultra-low levels of carfentanil[J]. Toxicol Sci，2019，167（2）：524-535. doi：10.1093/toxsci/kfy259 .
39	AMANTE E， ALLADIO E， RIZZO R， et al. Untargeted metabolomics in forensic toxicology： A new approach for the detection of fentanyl intake in urine samples[J]. Molecules，2021，26（16）：4990. doi：10.3390/molecules26164990 .
40	ZAITSU K， HAYASHI Y， SUZUKI K， et al. Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201[J]. Life Sci，2015，137：49-55. doi：10.1016/j.lfs.2015.05.013 .
41	MARKIN P A， BRITO A， MOSKALEVA N E， et al. Short- and long-term exposures of the synthetic cannabinoid 5F-APINAC induce metabolomic alterations associated with neurotransmitter systems and embryoto-xicity confirmed by teratogenicity in zebrafish[J]. Comp Biochem Physiol C Toxicol Pharmacol，2021，243：109000. doi：10.1016/j.cbpc.2021.109000 .
42	OLESTI E， DE TOMA I， RAMAEKERS J G， et al. Metabolomics predicts the pharmacological profile of new psychoactive substances[J]. J Psychopharmacol，2019，33（3）：347-354. doi：10.1177/0269881118812103 .
43	刘闯. 条件性位置偏爱试验[J].中国药物滥用防治杂志，1996，2（4）：37-39.
	LIU C. Conditional place preference test[J]. Zhongguo Yaowu Lanyong Fangzhi Zazhi，1996，2（4）：37-39.
44	MENG J R， ZHANG X D， WU H， et al. Morphine-induced conditioned place preference in mice： Metabolomic profiling of brain tissue to find “molecular switch” of drug abuse by gas chromatography/mass spectrometry[J]. Anal Chimica Acta，2012，710：125-130. doi：10.1016/j.aca.2011.09.033 .
45	LI H， BU Q， CHEN B， et al. Mechanisms of metabonomic for a gateway drug： Nicotine priming enhances behavioral response to cocaine with modification in energy metabolism and neurotransmitter level[J]. PLoS One，2014，9（1）： e87040. doi：10.1371/journal.pone.0087040 .
46	GUO R， TANG Q X， YE Y， et al. Effects of gender on ketamine-induced conditioned placed preference and urine metabonomics[J]. Regul Toxicol Pharmacol，2016，77：263-274. doi：10.1016/j.yrtph.2016.03.007 .
47	ZAITSU K， HAYASHI Y， KUSANO M， et al. Application of metabolomics to toxicology of drugs of abuse： A mini review of metabolomics approach to acute and chronic toxicity studies[J]. Drug Metab Pharmacokinet，2016，31（1）：21-26. doi：10.1016/j.dmpk.2015.10.002 .
48	LI Y， YAN G Y， ZHOU J Q， et al. ¹H NMR-based metabonomics in brain nucleus accumbens and striatum following repeated cocaine treatment in rats[J]. Neuroscience，2012，218：196-205. doi：10.1016/j.neuroscience.2012.05.019 .
49	BU Q， LV L， YAN G Y， et al. NMR-based metabonomic in hippocampus， nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats[J]. Neuro Toxicology，2013，36：17-23. doi：10.1016/j.neuro.2013.02.007 .
50	LIN M， XU J M， LIU X， et al. Metabolomics profiling of methamphetamine addicted human serum and three rat brain areas[J]. RSC Adv，2019，9（70）：41107-41119. doi：10.1039/c9ra08096a .
51	KIM S， JANG W J， YU H， et al. Revealing metabolic perturbation following heavy methamphetamine abuse by human hair metabolomics and network analysis[J]. Int J Mol Sci，2020，21（17）： E6041. doi：10.3390/ijms21176041 .
52	ZHOU J， LI Y， YAN G， et al. Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress[J]. Neurotox Res，2011，20（4）：334-342. doi：10.1007/s12640-011-9247-x .
53	OJA S S， SARANSAARI P. Pharmacology of taurine[J]. Proc West Pharmacol Soc，2007，50：8-15.
54	MANJI H K， MOORE G J， RAJKOWSKA G， et al. Neuroplasticity and cellular resilience in mood disorders[J]. Mol Psychiatry，2000，5（6）：578-593. doi：10.1038/sj.mp.4000811 .
55	DOLE V P， NYSWANDER M E. Heroin addiction --A metabolic disease[J]. Arch Intern Med，1967，120（1）：19-24. doi：10.1001/archinte.1967.00300010021004 .
56	ZHENG T， LIU L S， AA J Y， et al. Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse[J]. Drug Alcohol Dependence，2013，127（1/2/3）：177-186. doi：10.1016/j.drugalcdep.2012.06.031 .
57	NING T， LENG C， CHEN L， et al. Metabolomics analysis of serum in a rat heroin self-administration model undergoing reinforcement based on ¹H-nuclear magnetic resonance spectra[J]. BMC Neurosci，2018，19（1）：4. doi：10.1186/s12868-018-0404-5 .
58	闫娟，李林熹，张波. 代谢组学在常见毒品滥用中的研究进展[J].川北医学院学报，2017，32（2）：306-309，314. doi：10.3969/j.issn.1005-3697.2017.02.043 .
	YAN J， LI L X， ZHANG B. Research progress of metabonomics in common drug abuse[J]. Chuanbei Yixueyuan Xuebao，2017，32（2）：306-309，314.
59	吴明健，王玫，杨瑞琴，等. 基于液相色谱联合离子阱-飞行时间质谱技术的海洛因滥用成瘾大鼠血清代谢组学研究[J].分析试验室，2014，33（2）：183-186. doi：10.13595/j.cnki.issn1000-0720.2014.0041 .
	WU M J， WANG M， YANG R Q， et al. Metabonomics study of serum in heroin abused rats by liquid chromatography coupled with ion trap-time of flight mass spectrometry[J]. Fenxi Shiyanshi，2014，33（2）：183-186.
60	吴明健，王玫，彭明丽，等. 运用液相色谱联合离子阱-飞行时间质谱法进行海洛因成瘾人员代谢组学研究[J].分析化学，2014，42（4）：602-606. doi：10.3724/SP.J.1096.2014.30953 .
	WU M J， WANG M， PENG M L， et al. A metabonomics study on heroin addicts using liquid chromatography coupled with ion trap-time of flight mass spectrometry[J]. Fenxi Huaxue，2014，42（4）：602-606.
61	DINIS-OLIVEIRA R J. Metabolism and metabolomics of opiates： A long way of forensic implications to unravel[J]. J Forensic Leg Med，2019，61：128-140. doi：10.1016/j.jflm.2018.12.005 .
62	GHANBARI R， LI Y Y， PATHMASIRI W， et al. Metabolomics reveals biomarkers of opioid use disorder[J]. Transl Psychiatry，2021，11：103. doi：10.1038/s41398-021-01228-7 .

[1]	Wen LI, Hao-zhe LI, Chen CHEN, Wei-xiong CAI. Research Progress and Application Prospect of Facial Micro-Expression Analysis in Forensic Psychiatry [J]. Journal of Forensic Medicine, 2023, 39(5): 493-500.
[2]	Zhong-hua WANG, Shu-jin LI. Research Progress on Molecular Biology of Human Height Estimation [J]. Journal of Forensic Medicine, 2023, 39(5): 487-492.
[3]	Cui-mei LIU, Wei JIA, Chun-hui SONG, Zhen-hua QIAN, Zhen-dong HUA, Yue-meng CHEN. Qualitative and Quantitative Analysis of Five Indoles or Indazole Amide Synthetic Cannabinoids in Suspected E-Cigarette Oil by GC-MS [J]. Journal of Forensic Medicine, 2023, 39(5): 457-464.
[4]	Lu CHEN, Zhe ZHOU, Sheng-qi WANG. Process of Forensic Medicine in DNA Identification of Aged Human Remains [J]. Journal of Forensic Medicine, 2023, 39(5): 478-486.
[5]	Yong ZENG, Dong-hua ZOU, Ying FAN, Qing XU, Lu-yang TAO, Yi-jiu CHEN, Zheng-dong LI. Research Progress and Forensic Application of Human Vascular Finite Element Modeling and Biomechanics [J]. Journal of Forensic Medicine, 2023, 39(5): 471-477.
[6]	Wen-ya ZHAI, Li-na WU, Shuo YANG, Bao-hua SHEN, Yan SHI. Detection and Analysis of Blood Dexmedetomidine in Drug-Facilitated Cases [J]. Journal of Forensic Medicine, 2023, 39(5): 452-456.
[7]	Fei FAN, Juan WU, Zhen-hua DENG. Application Progress of Objective Audiological Detection Techniques in Forensic Clinical Medicine [J]. Journal of Forensic Medicine, 2023, 39(4): 360-366.
[8]	Qing-qing XIANG, Li-fang CHEN, Qin SU, Yu-kun DU, Pei-yan LIANG, Xiao-dong KANG, He SHI, Qu-yi XU, Jian ZHAO, Chao LIU, Xiao-hui CHEN. Research Progress on Microbial Community Succession in the Postmortem Interval Estimation [J]. Journal of Forensic Medicine, 2023, 39(4): 399-405.
[9]	Qin SU, Qian-ling CHEN, Wei-bin WU, Qing-qing XIANG, Cheng-liang YANG, Dong-fang QIAO, Zhi-gang LI. Metabonomics Analysis of Brain Stem Tissue in Rats with Primary Brain Stem Injury Caused Death [J]. Journal of Forensic Medicine, 2023, 39(4): 373-381.
[10]	Yu-qi CAO, Yan SHI, Ping XIANG, Yin-long GUO. Research Progress on Machine Learning Assisted Non-Targeted Screening Strategy for Identification of Fentanyl Analogs [J]. Journal of Forensic Medicine, 2023, 39(4): 406-416.
[11]	Ran LI, Hong-yu SUN. Methods and Research Hotspots of Forensic Kinship Testing [J]. Journal of Forensic Medicine, 2023, 39(3): 231-239.
[12]	Xiao-yan MA, Hong-yu SUN, Qing LI. Research Progresses of Tri-Allelic Patterns in Autosomal STR in Forensic DNA Analysis [J]. Journal of Forensic Medicine, 2023, 39(3): 240-246.
[13]	Hang CHEN, Jing HU, Zheng QIAO, Hong-xiao DENG, Min LÜ, Wei LIU. Research Progress on Biological Matrix Reference Materials in Forensic Toxicology [J]. Journal of Forensic Medicine, 2023, 39(2): 176-185.
[14]	Hong-yan GAO, Guang-fu LIU, Jian WU, Peng-yu CHEN. Animal DNA Typing and Its Research Progress in Forensic Medicine [J]. Journal of Forensic Medicine, 2023, 39(2): 161-167.
[15]	Wu LONG, Peng-fei QU, Lin MA, Rui WANG, Yan-mei XI, Yu-hua LI, Sheng-jie NIE, Ting DUAN, Jin-liang DU, Xue TANG, Jing-feng ZHAO, Pu-ping LEI, Yue-bing WANG. Cytotoxicity of 4 Wild Mushrooms in a Case of Yunnan Sudden Unexplained Death [J]. Journal of Forensic Medicine, 2023, 39(2): 121-128.